The screened hub genes, PIK3R1, SPNB2, and CRYAB, have been validated as credible molecular biomarkers using the mouse MI model and human blood samples, which may provide a novel therapy for cardiac diseases with increased proteotoxic stress. The gene discussed is CRYAB; the disease is myocardial infarction.